Turoctocog alfa pegol is an extended half-life factor VIII molecule for treatment and prophylaxis of bleeding episodes and perioperative management in adults and children with hemophilia A. FDA Approvals

In a study of more than 1100 participants, perioperative covert stroke occurred in 1 in every 14 patients — and was associated with increased risk for cognitive decline within 1 year postsurgery. Medscape Medical News